Shanmugam Muthusamy 4
4 · ANI PHARMACEUTICALS INC · Filed May 17, 2024
Insider Transaction Report
Form 4
Shanmugam Muthusamy
DirectorHEAD OF R&D, COO-NOVITIUM OPS
Transactions
- Sale
Common Stock
2024-05-15$65.86/sh−14,850$978,021→ 767,770 total(indirect: By LLC) - Sale
Common Stock
2024-05-16$63.84/sh−16,459$1,050,743→ 751,311 total(indirect: By LLC) - Sale
Common Stock
2024-05-17$62.09/sh−5,836$362,357→ 745,475 total(indirect: By LLC)
Holdings
- 68,652
Common Stock
- 5,000(indirect: By LLC)
Common Stock
Footnotes (6)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2023.
- [F2]The shares were sold in multiple trades at prices ranging from $64.66 to $66.54. The price reported above reflects the weighted average sales price.
- [F3]The reporting person holds voting and dispositive power over the shares held by Esjay LLC.
- [F4]The shares were sold in multiple trades at prices ranging from $63.28 to $64.90. The price reported above reflects the weighted average sales price.
- [F5]The shares were sold in multiple trades at prices ranging from $61.43 to $64.00. The price reported above reflects the weighted average sales price.
- [F6]The Reporting Person holds voting and dispositive power over the shares held by SS Pharma LLC.